Business
Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy
SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today said it has signed a joint venture (JV) company agreement with Singapore-based Aiodine Laboratory Pte Ltd. (“Aiodine”) to develop, test and market that company’s novel iodine-based disinfectant solution as a treatment for chronic and acute wounds, an
About this update from Cuprina Holdings (cayman) Limited
[{"type":"image","alt":"Cuprina Holdings (Cayman) LTD","displaySize":"","headline":null,"caption":"Cuprina Holdings (Cayman) LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/402f43f30f35f5ccdd587985aebd2fe7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Vs5DV_xDy69c4LSgVE319A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/402f43f30f35f5ccdd587985aebd2fe7","width":300,"height":73}},"lazy":false},{"type":"text","content":"SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today said it has signed a joint venture (JV) company agreement with Singapore-based Aiodine Laboratory Pte Ltd. (“Aiodine”) to develop, test and market that company’s novel iodine-based disinfectant solution as a treatment for chronic and acute wounds, and in other common antiseptic applications.","length":542,"tagName":"p"},{"type":"text","content":"Initial applications for this iodine-based solution will focus on an antiseptic wound care formulation, disinfectants, and daily home-use antiseptics, with additional opportunities under evaluation in personal care, oral hygiene and veterinary applications. The companies plan to commence the clinical studies required to achieve regulatory approvals for these applications in 2026.","length":382,"tagName":"p"},{"type":"text","content":"According to the JV company agreement, Cuprina shall be responsible for implementing global sales strategies, marketing campaigns, and distribution networks for licensed products. Aiodine Laboratory shall be responsible for providing the JV with its proprietary iodine technology and technical expertise.","length":304,"tagName":"p"},{"type":"text","content":"The iodine-based solution works by penetrating pathogens and attacking their amino acids, nucleotides, and fatty acids, causing damage to their structures and leading to their death or destruction. In a study conducted at First Affiliated Hospital of Hainan Medical University, Haikou, China and published in the March 26, 2025 edition of the peer-reviewed Wounds International, the solution was evaluated for safety and...